BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38429660)

  • 1. Evaluating the comprehensive diagnosis efficiency of lung cancer, including measurement of SHOX2 and RASSF1A gene methylation.
    Liu J; Bian T; She B; Liu L; Sun H; Zhang Q; Zhu J; Zhang J; Liu Y
    BMC Cancer; 2024 Mar; 24(1):282. PubMed ID: 38429660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Methylation of
    Zhong Q; Wang Y; Liang C; Wei F; She B
    Discov Med; 2023 Oct; 35(178):845-852. PubMed ID: 37811622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis.
    Ilse P; Biesterfeld S; Pomjanski N; Wrobel C; Schramm M
    Cancer Genomics Proteomics; 2014; 11(5):251-8. PubMed ID: 25331797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis.
    Zhang C; Yu W; Wang L; Zhao M; Guo Q; Lv S; Hu X; Lou J
    J Cancer; 2017; 8(17):3585-3591. PubMed ID: 29151944
    [No Abstract]   [Full Text] [Related]  

  • 5. Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer.
    Li N; Zeng Y; Huang J
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1379-1393. PubMed ID: 32266538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of SHOX2, RASSF1A gene methylation combined with CEA level detection in malignant pleural effusion.
    Chen S; Huang K; Zou L; Chen L; Hu P
    BMC Pulm Med; 2023 May; 23(1):160. PubMed ID: 37158875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of exfoliated tumor cells combined with DNA methylation in bronchoalveolar lavage fluid for lung cancer.
    Lu H; Lin D
    Medicine (Baltimore); 2023 Sep; 102(36):e34955. PubMed ID: 37682182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of RASSF1A and SHOX2 methylation combined with EGFR mutations for differentiation between small pulmonary nodules.
    Ji XY; Li H; Chen HH; Lin J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8557-8571. PubMed ID: 37097393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
    Huang W; Huang H; Zhang S; Wang X; Ouyang J; Lin Z; Chen P
    Cancer Control; 2020; 27(1):1073274820969703. PubMed ID: 33167712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance Evaluation of
    Shi J; Chen X; Zhang L; Fang X; Liu Y; Zhu X; Zhang H; Fan L; Gu J; Zhang S; She B; Han H; Yi X
    Front Oncol; 2020; 10():565780. PubMed ID: 33425721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Diagnostic Potential of
    Gao H; Yang J; He L; Wang W; Liu Y; Hu Y; Ge M; Ding J; Ye Q
    Front Oncol; 2022; 12():849024. PubMed ID: 35837113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of SHOX2 and RASSF1A methylation assay in supernatants and matched cell pellets for the diagnosis of malignant pleural effusion.
    Zhang N; Li Y; Zhang H; Dong Y; Zhang C; Du W; Long C; Xing X; Li K; Liu Z; Chen X; Zhang L; Xu F; Fu Y; Tan J; She B; Che N
    Clin Chim Acta; 2024 Jan; 553():117699. PubMed ID: 38072300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Methylation Analysis of the
    Zhang N; Liu Z; Li K; Xing X; Long C; Liu F; She B; Che N
    J Oncol; 2023; 2023():5888844. PubMed ID: 36691467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHOX2 methylation in Vietnamese patients with lung cancer.
    Vo TTL; Nguyen TN; Nguyen TT; Pham ATD; Vuong DL; Ta VT; Ho VS
    Mol Biol Rep; 2022 May; 49(5):3413-3421. PubMed ID: 35088378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA methylation detection of SHOX2 and PTGER4 in plasma contributes to differential diagnosis of pulmonary nodule patients].
    Chu X; Zhao W; Wang B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Apr; 35(4):357-361. PubMed ID: 31167696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
    Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
    J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
    Liu Q; Wang S; Pei G; Yang Y; Huang Y
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A detection panel of novel methylated DNA markers for malignant pleural effusion.
    Liang C; Liu N; Zhang Q; Deng M; Ma J; Lu J; Yin Y; Wang J; Miao Y; She B; Li Q; Hou G
    Front Oncol; 2022; 12():967079. PubMed ID: 36176402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of unmethylated RASSF1A on disease progression in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy.
    Deng Q; Su B; Ji X; Fang Q; Zhou S; Zhou C
    Cancer Biomark; 2020; 27(3):313-323. PubMed ID: 31839603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-375 Combined with SHOX2 Methylation has Higher Diagnostic Efficacy for Non-Small-Cell Lung Cancer.
    Zeng S; Lin C; Huang Y
    Mol Biotechnol; 2023 Jul; 65(7):1187-1197. PubMed ID: 36462101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.